Klaus Pietzner

Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Radoslav Chekerov, Felix Hilpert, Sven� Mahner et al. · The Lancet Oncology · 2018 · 108 citations

Oncology, Medicine, Metronomic Therapy +8

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial

Nicoletta Colombo, Elena Biagioli, Kenichi Harano et al. · The Lancet Oncology · 2024 · 89 citations

Gynecological Surgery, Medicine, Metronomic Therapy +6

Magnetic Resonance Imaging–Guided Balloon Angioplasty of Coarctation of the Aorta

Julia Krueger, Peter Ewert, Sevim Yilmaz et al. · Circulation · 2006 · 79 citations

Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers

Elena Ioana Braicu, Jalid Sehouli, Ralf P. Richter et al. · British Journal of Cancer · 2011 · 71 citations · Full text

Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study

Jalid Sehouli, Klaus Pietzner, Philipp Harter et al. · Annals of Oncology · 2010 · 50 citations · Full text

Neuro-oncology, Tumoral Pathology, Medicine +8